CVRx (NASDAQ: CVRX)
$7.80
(3.0%)
$0.23
Price as of August 22, 2025, 4:00 p.m. ET
CVRx Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
CVRx Company Info
CVRx, Inc. engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It operates through the United States, Germany, and Other Countries geographical segments. The company was founded by Robert S. Kieval and Tyler P. Lipschultz in August 2000 and is headquartered in Minneapolis, MN.
News & Analysis
Featured Article
CVRx (CVRX) Q2 Revenue Jumps 15%
Motley Fool Markets Team | Aug 4, 2025
Featured Article
What Companies Does Johnson & Johnson Own?
Matt DiLallo | Jun 5, 2025
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.